World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00004787
Date of registration: 24/02/2000
Prospective Registration: No
Primary sponsor: National Center for Research Resources (NCRR)
Public title: Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
Scientific title:
Date of first enrolment: December 1994
Target sample size: 20
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00004787
Study type:  Interventional
Study design:  Primary Purpose: Treatment  
Phase:  Phase 2
Countries of recruitment
Contacts
Name:     David A. Williams
Address: 
Telephone:
Email:
Affiliation:  James Whitcomb Riley Hospital for Children
Key inclusion & exclusion criteria

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

Inherited bone marrow failure syndrome, including:

- Fanconi's anemia

- Dyskeratosis congenita

- Shwachman syndrome

- Amegakaryocytic thrombocytopenia

- Decreased megakaryocytes in infancy

- No thrombocytopenia with absent radius syndrome (TAR)

- No trisomy 13 or 18

- No clonal bone marrow karyotype

--Prior/Concurrent Therapy--

- At least 4 weeks since growth factors

- Concurrent therapy allowed if not altered for 30 days prior to entry through week 8

- No concurrent investigational drugs

--Patient Characteristics--

- Hematopoietic: ANC <1000

- No leukemia

- Other: No medical or psychiatric contraindication to protocol participation

- No pregnant or nursing women



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Fanconi's Anemia
Dyskeratosis Congenita
Thrombocytopenia
Shwachman Syndrome
Intervention(s)
Drug: filgrastim
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
199/11877
UTMB-416
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
James Whitcomb Riley Hospital for Children
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history